Viewing Study NCT06377267


Ignite Creation Date: 2025-12-25 @ 12:41 AM
Ignite Modification Date: 2025-12-28 @ 7:54 PM
Study NCT ID: NCT06377267
Status: RECRUITING
Last Update Posted: 2024-05-09
First Post: 2024-04-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
Sponsor: Vall d'Hebron Institute of Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module